{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:26:27Z","timestamp":1789586787478,"version":"build-2803163510"},"reference-count":127,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nanomedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.nano.2014.02.014","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T14:31:17Z","timestamp":1394807477000},"page":"1139-1151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Intestinal absorption of insulin nanoparticles: Contribution of M cells"],"prefix":"10.1016","volume":"10","author":[{"given":"Marlene Almeida","family":"Lopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara Azevedo","family":"Abrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio Mendes","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Rangel","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel Maria Fino","family":"Sei\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jos\u00e9","family":"de Baptista Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio Jos\u00e9","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2014.02.014_bb0005","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.carbpol.2011.10.002","article-title":"Improving intestinal insulin absorption efficiency through coadministration of cell-penetrating peptide and hydroxypropyl-\u03b2-cyclodextrin","volume":"87","author":"Zhang","year":"2012","journal-title":"Carbohyd Polym"},{"key":"10.1016\/j.nano.2014.02.014_bb0010","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1681\/ASN.V13suppl_1s92","article-title":"Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration","volume":"13","author":"Quellhorst","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nano.2014.02.014_bb0015","first-page":"106","article-title":"Inhalation insulin and oral and nasal insulin sprays for diabetics: panacea or evolving future health disaster part II","author":"Shantha TRS","year":"2009","journal-title":"Townsend Letter"},{"key":"10.1016\/j.nano.2014.02.014_bb0020","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1002\/app.34315","article-title":"Glutamine-chitosan microparticles as oral insulin delivery matrix: in vitro characterization","volume":"122","author":"Rekha","year":"2011","journal-title":"J Appl Polym Sci"},{"key":"10.1016\/j.nano.2014.02.014_bb0025","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jconrel.2009.08.010","article-title":"Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis","volume":"140","author":"Roger","year":"2009","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.02.014_bb0030","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tibtech.2009.07.009","article-title":"Therapeutic application of peptides and proteins: parenteral forever?","volume":"27","author":"Antosova","year":"2009","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.nano.2014.02.014_bb0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jconrel.2010.02.001","article-title":"A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa","volume":"149","author":"Makhlof","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.02.014_bb0040","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1002\/jps.21347","article-title":"Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response","volume":"97","author":"Reis","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2014.02.014_bb0045","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1021\/mp200572t","article-title":"Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations","volume":"9","author":"Sonaje","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2014.02.014_bb0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejpb.2004.03.032","article-title":"Thiomers: potential excipients for non-invasive peptide delivery systems","volume":"58","author":"Bernkop-Schnurch","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2014.02.014_bb0055","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.chroma.2007.07.036","article-title":"Process and purification for manufacture of a modified insulin intended for oral delivery","volume":"1177","author":"Dave","year":"2008","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.nano.2014.02.014_bb0060","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.biomaterials.2011.12.038","article-title":"Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery","volume":"33","author":"Su","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2014.02.014_bb0065","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2174\/138920007780866834","article-title":"Presystemic metabolism of orally administered peptide drugs and strategies to overcome it","volume":"8","author":"Bernkop-Schnurch","year":"2007","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.nano.2014.02.014_bb0070","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/jps.2600840604","article-title":"Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine","volume":"84","author":"Asada","year":"1995","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2014.02.014_bb0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2006.12.022","article-title":"A novel approach using functional peptides for efficient intestinal absorption of insulin","volume":"118","author":"Morishita","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.02.014_bb0080","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2006.12.003","article-title":"A novel vitamin B12\u2013nanosphere conjugate carrier system for peroral delivery of insulin","volume":"117","author":"Chalasani","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.02.014_bb0085","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/cmdc.200700239","article-title":"Vitamin B(12) as a carrier for the oral delivery of insulin","volume":"2","author":"Petrus","year":"2007","journal-title":"Chemmedchem"},{"key":"10.1016\/j.nano.2014.02.014_bb0090","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijpharm.2006.06.019","article-title":"Cyclodextrin\u2013insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery","volume":"325","author":"Sajeesh","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2014.02.014_bb0095","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jconrel.2005.10.029","article-title":"Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats","volume":"110","author":"Morishita","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.02.014_bb0100","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.carbpol.2011.04.011","article-title":"A novel pH-sensitive hydrogel based on dual crosslinked alginate\/N-alpha-glutaric acid chitosan for oral delivery of protein","volume":"85","author":"Gong","year":"2011","journal-title":"Carbohyd Polym"},{"key":"10.1016\/j.nano.2014.02.014_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1088\/0957-4484\/18\/10\/105102","article-title":"Novel nanoparticles for oral insulin delivery via the paracellular pathway","volume":"18","author":"Lin","year":"2007","journal-title":"Nanotechnology"},{"key":"10.1016\/j.nano.2014.02.014_bb0110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijpharm.2005.01.018","article-title":"Investigation of lectin-modified insulin liposomes as carriers for oral administration","volume":"294","author":"Zhang","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2014.02.014_bb0115","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijpharm.2005.09.028","article-title":"Effects of absorption promoters on insulin absorption through colon-targeted delivery","volume":"307","author":"Katsuma","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2014.02.014_bb0120","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.addr.2011.10.006","article-title":"Oral colon delivery of insulin with the aid of functional adjuvants","volume":"64","author":"Maroni","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2014.02.014_bb0125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/(SICI)1098-2299(200002)49:2<109::AID-DDR4>3.0.CO;2-#","article-title":"Insulin-loaded nanocapsules for oral administration: in vitro and in vivo investigation","volume":"49","author":"Aboubakar","year":"2000","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.nano.2014.02.014_bb0130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4103\/0250-474X.42967","article-title":"Protein and peptide drug delivery: oral approaches","volume":"70","author":"Shaji","year":"2008","journal-title":"Indian J Pharm Sci"},{"key":"10.1016\/j.nano.2014.02.014_bb0135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijpharm.2011.04.003","article-title":"Facilitated nanoscale delivery of insulin across intestinal membrane models","volume":"412","author":"Woitiski","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2014.02.014_bb0140","first-page":"743","article-title":"Oral insulin delivery by means of solid lipid nanoparticles","volume":"2","author":"Sarmento","year":"2007","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2014.02.014_bb0145","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2014.02.014_bb0150","series-title":"Drug delivery systems: advanced technologies potentially applicable in personalised treatment","first-page":"109","article-title":"4 Nanoparticles for oral delivery of insulin","author":"Ribeiro","year":"2013"},{"key":"10.1016\/j.nano.2014.02.014_bb0155","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.2042-7158.1990.tb07033.x","article-title":"Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency","volume":"42","author":"Jani","year":"1990","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.nano.2014.02.014_bb0160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1011981610840","article-title":"Utilizing bacterial mechanisms of epithelial cell entry: invasin-induced oral uptake of latex nanoparticles","volume":"15","author":"Hussain","year":"1998","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2014.02.014_bb0165","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1023\/A:1012153011884","article-title":"Enhanced oral uptake of tomato lectin-conjugated nanoparticles in the rat","volume":"14","author":"Hussain","year":"1997","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2014.02.014_bb0170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jconrel.2006.10.023","article-title":"Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats","volume":"117","author":"Damge","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.02.014_bb0175","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpb.2012.10.003","article-title":"Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs","volume":"83","author":"Antunes","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2014.02.014_bb0180","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1016\/j.biomaterials.2011.08.087","article-title":"A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery","volume":"32","author":"Chen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2014.02.014_bb0185","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cocis.2010.12.005","article-title":"Fate of polymeric nanocarriers for oral drug delivery","volume":"16","author":"Plapied","year":"2011","journal-title":"Curr Opin Colloid In"},{"key":"10.1016\/j.nano.2014.02.014_bb0190","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1359-6446(04)03354-9","article-title":"Cell culture-based models for intestinal permeability: a critique","volume":"10","author":"Balimane","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.nano.2014.02.014_bb0195","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1006\/bbrc.2000.4038","article-title":"Expression of specific markers and particle transport in a new human intestinal M-cell model","volume":"279","author":"Gullberg","year":"2000","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/j.nano.2014.02.014_bb0200","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1016\/j.ces.2009.04.050","article-title":"Impact of absorption and transport on intelligent therapeutics and nanoscale delivery of protein therapeutic agents","volume":"64","author":"Peppas","year":"2009","journal-title":"Chem Eng Sci"},{"key":"10.1016\/j.nano.2014.02.014_bb0205","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s13346-011-0023-5","article-title":"Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin","volume":"1","author":"Fonte","year":"2011","journal-title":"Drug Deliv Transplant Res"},{"key":"10.1016\/j.nano.2014.02.014_bb0210","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/jbm.a.32395","article-title":"Assessment of poly(methacrylic acid-co-N-vinyl pyrrolidone) as a carrier for the oral delivery of therapeutic proteins using Caco-2 and HT29-MTX cell lines","volume":"92A","author":"Carr","year":"2010","journal-title":"J Biomed Mater Res Part A"},{"key":"10.1016\/j.nano.2014.02.014_bb0215","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ejps.2005.04.015","article-title":"Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium","volume":"25","author":"des Rieux","year":"2005","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2014.02.014_bb0220","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejps.2009.11.002","article-title":"Transport of chitosan-DNA nanoparticles in human intestinal M-cell model versus normal intestinal enterocytes","volume":"39","author":"Kadiyala","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2014.02.014_bb0225","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/nbt1332","article-title":"Exploiting lymphatic transport and complement activation in nanoparticle vaccines","volume":"25","author":"Reddy","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nano.2014.02.014_bb0230","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jamcollsurg.2011.11.006","article-title":"Nanoparticle migration and delivery of paclitaxel to regional lymph nodes in a large animal model","volume":"214","author":"Khullar","year":"2012","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.nano.2014.02.014_bb0235","first-page":"271","article-title":"Nanotechnology as a promising strategy for alternative routes of insulin delivery","volume":"508","author":"Reis","year":"2012","journal-title":"Nanomed-Special Issue: Methods Enzimol"},{"key":"10.1016\/j.nano.2014.02.014_bb0240","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/mi.2012.4","article-title":"Oral tolerance to food protein","volume":"5","author":"Pabst","year":"2012","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.nano.2014.02.014_bb0245","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/jps.21970","article-title":"Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery","volume":"99","author":"Rao","year":"2010","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2014.02.014_bb0250","first-page":"39","article-title":"Nanostructures overcoming the intestinal barrier: physiological considerations and mechanistic issues: In: Alonso MJ, Csaba NS, editors. Nanostructured biomaterials for overcoming biological barriers","author":"Maher","year":"2012","journal-title":"Royal Society Chemistry"},{"key":"10.1016\/j.nano.2014.02.014_bb0255","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.colsurfb.2004.05.007","article-title":"Interaction of PLGA nanoparticles with human blood constituents","volume":"40","author":"Kim","year":"2005","journal-title":"Colloid Surf B"},{"key":"10.1016\/j.nano.2014.02.014_bb0260","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1124\/pr.111.005363","article-title":"Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles","volume":"64","author":"Morachis","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.nano.2014.02.014_bb0265","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0169-409X(98)00039-8","article-title":"Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics","volume":"34","author":"All\u00e9mann","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2014.02.014_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.08.013","article-title":"Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach","volume":"116","author":"des Rieux","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.02.014_bb0275","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/jps.21550","article-title":"Modified chitosans for oral drug delivery","volume":"98","author":"Werle","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2014.02.014_bb0280","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s00018-009-0053-z","article-title":"Nanocarriers' entry into the cell: relevance to drug delivery","volume":"66","author":"Hillaireau","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.nano.2014.02.014_bb0285","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nature01451","article-title":"Regulated portals of entry into the cell","volume":"422","author":"Conner","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.nano.2014.02.014_bb0290","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.addr.2007.06.008","article-title":"Endocytic mechanisms for targeted drug delivery","volume":"59","author":"Bareford","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2014.02.014_bb0295","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2567.2006.02335.x","article-title":"Drinking a lot is good for dendritic cells","volume":"117","author":"Norbury","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.nano.2014.02.014_bb0300","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0168-3659(87)90069-1","article-title":"Carrier mediated transport of amino acids, small peptides, and their drug analogs","volume":"6","author":"Sinko","year":"1987","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.02.014_bb0305","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0169-409X(98)00037-4","article-title":"The effect of physical barriers and properties on the oral absorption of particulates","volume":"34","author":"Norris","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2014.02.014_bb0310","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00063030-200519030-00003","article-title":"Oral delivery of peptide drugs\u2014barriers and developments","volume":"19","author":"Hamman","year":"2005","journal-title":"BioDrugs"},{"key":"10.1016\/j.nano.2014.02.014_bb0315","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","article-title":"Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs","volume":"6","author":"Porter","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nano.2014.02.014_bb0320","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1002\/jps.21762","article-title":"Analysis of unstirred water layer in in vitro permeability experiments","volume":"98","author":"Korjamo","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2014.02.014_bb0325","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00003088-200140020-00001","article-title":"Bioadhesion\u2014new possibilities for drug administration?","volume":"40","author":"Woodley","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.nano.2014.02.014_bb0330","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/jbm.b.31161","article-title":"Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin","volume":"88B","author":"Wang","year":"2009","journal-title":"J Biomed Mater Res Part B"},{"key":"10.1016\/j.nano.2014.02.014_bb0335","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1016\/j.biomaterials.2009.06.055","article-title":"Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery","volume":"30","author":"Yin","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2014.02.014_bb0340","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1002\/jps.21783","article-title":"The role of mucoadhesion of trimethyl chitosan and PEGylated trimethyl chitosan nanocomplexes in insulin uptake","volume":"98","author":"Jintapattanakit","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2014.02.014_bb0345","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2009.01.011","article-title":"Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption","volume":"135","author":"Rekha","year":"2009","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.02.014_bb0350","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ejps.2012.01.002","article-title":"Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration","volume":"45","author":"Zhang","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2014.02.014_bb0355","first-page":"295","article-title":"Chitosan-coated solid lipid nanoparticles for insulin delivery","volume":"508","author":"Fonte","year":"2012","journal-title":"Nanomed\u2014Special issue: Methods Enzimol"},{"key":"10.1016\/j.nano.2014.02.014_bb0360","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.biomaterials.2011.10.075","article-title":"Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport","volume":"33","author":"Jin","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2014.02.014_bb0365","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1021\/mp300649z","article-title":"Improved transport and absorption through gastrointestinal tract by pegylated solid lipid nanoparticles","volume":"10","author":"Yuan","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2014.02.014_bb0370","doi-asserted-by":"crossref","first-page":"19268","DOI":"10.1073\/pnas.0905998106","article-title":"Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier","volume":"106","author":"Tang","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nano.2014.02.014_bb0375","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2014.02.014_bb0380","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.addr.2012.10.007","article-title":"Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery","volume":"65","author":"Yun","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2014.02.014_bb0385","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0169-409X(91)90013-3","article-title":"Mechanisms od peptide and protein-absorption. 1. Paracellular intestinal transport\u2014modulation of absorption","volume":"7","author":"Nellans","year":"1991","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2014.02.014_bb0390","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02209145","article-title":"Contribution of solvent drag through intercellular-junctions to absorption of nutrients by the small-intestine of the rat","volume":"100","author":"Pappenheimer","year":"1987","journal-title":"J Membr Biol"},{"key":"10.1016\/j.nano.2014.02.014_bb0395","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1016\/j.biomaterials.2010.01.042","article-title":"Enteric-coated capsules filled with freeze-dried chitosan\/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery","volume":"31","author":"Sonaje","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2014.02.014_bb0400","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1172\/JCI108154","article-title":"Morphological basis for intercellular communication between alpha-cells and beta-cells in endocrine pancreas","volume":"56","author":"Orci","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nano.2014.02.014_bb0405","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2005.01.022","article-title":"Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium","volume":"294","author":"Salamat-Miller","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2014.02.014_bb0410","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2008.08.020","article-title":"Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs","volume":"132","author":"Lin","year":"2008","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.02.014_bb0415","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejpb.2008.03.004","article-title":"Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells","volume":"70","author":"Sadeghi","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2014.02.014_bb0420","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1021\/ar200234q","article-title":"pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications","volume":"45","author":"Sung","year":"2012","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.nano.2014.02.014_bb0425","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.1016\/j.biomaterials.2010.05.042","article-title":"Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: oral delivery using pH-responsive nanoparticles vs. subcutaneous injection","volume":"31","author":"Sonaje","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2014.02.014_bb0430","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.biomaterials.2008.12.066","article-title":"In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery","volume":"30","author":"Sonaje","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2014.02.014_bb0435","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.biomaterials.2010.12.044","article-title":"The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo","volume":"32","author":"Nguyen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2014.02.014_bb0440","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1461-5347(99)00142-X","article-title":"Transcellular uptake mechanisms of the intestinal epithelial barrier\u2014part one","volume":"2","author":"Daugherty","year":"1999","journal-title":"Pharm Sci Technol Today"},{"key":"10.1016\/j.nano.2014.02.014_bb0445","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0167-7799(97)01170-0","article-title":"Innovative strategies for the oral delivery of drugs and peptides","volume":"16","author":"Fasano","year":"1998","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.nano.2014.02.014_bb0450","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.biopha.2004.01.006","article-title":"Principles of transmucosal delivery of therapeutic agents","volume":"58","author":"Blanchette","year":"2004","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.nano.2014.02.014_bb0455","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nantod.2011.02.003","article-title":"Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies","volume":"6","author":"Iversen","year":"2011","journal-title":"Nano Today"},{"key":"10.1016\/j.nano.2014.02.014_bb0460","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2012.08.024","article-title":"In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles","volume":"437","author":"Reix","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2014.02.014_bb0465","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s001250050081","article-title":"Biochemical and morpho-cytochemical evidence for the intestinal absorption of insulin in control and diabetic rats. Comparison between the effectiveness of duodenal and colon mucosa","volume":"37","author":"Bendayan","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/j.nano.2014.02.014_bb0470","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00404796","article-title":"Morpho-cytochemical and biochemical evidence for insulin absorption by the rat ileal epithelium","volume":"33","author":"Bendayan","year":"1990","journal-title":"Diabetologia"},{"key":"10.1016\/j.nano.2014.02.014_bb0475","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1021\/js9601400","article-title":"Transcellular delivery of an insulin-transferrin conjugate in enterocyte-like Caco-2 cells","volume":"85","author":"Shah","year":"1996","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2014.02.014_bb0480","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s11095-010-0345-x","article-title":"Uptake and transport of novel amphiphilic polyelectrolyte\u2013insulin nanocomplexes by Caco-2 cells\u2014towards oral insulin","volume":"28","author":"Thompson","year":"2011","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2014.02.014_bb0485","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1208\/s12249-012-9807-2","article-title":"Insulin-loaded pH-sensitive hyaluronic acid nanoparticles enhance transcellular delivery","volume":"13","author":"Han","year":"2012","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.nano.2014.02.014_bb0490","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2006.07.026","article-title":"Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin","volume":"327","author":"Zhang","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2014.02.014_bb0495","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10611860410001693760","article-title":"Use of targeting agents to increase uptake and localization of drugs to the intestinal epithelium","volume":"12","author":"Russell-Jones","year":"2004","journal-title":"J Drug Target"},{"key":"10.1016\/j.nano.2014.02.014_bb0500","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0014-5793(85)80927-3","article-title":"Tomato lectin resists digestion in the mammalian alimentary canal and binds to intestinal villi without deleterious effects","volume":"185","author":"Kilpatrick","year":"1985","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nano.2014.02.014_bb0505","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0168-3659(95)00059-H","article-title":"Nanoparticles as carriers for oral peptide absorption-studies on particles uptake and fate","volume":"36","author":"Florence","year":"1995","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.02.014_bb0510","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1023\/B:PHAM.0000045247.09724.26","article-title":"Binding and uptake of wheat germ agglutinin-grafted PLGA-nanospheres by Caco-2 monolayers","volume":"21","author":"Weissenboeck","year":"2004","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2014.02.014_bb0515","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1023\/A:1023406224028","article-title":"Wheat germ agglutinin binds to the epidermal growth factor receptor of artificial Caco-2 membranes as detected by silver nanoparticle enhanced fluorescence","volume":"20","author":"Lochner","year":"2003","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2014.02.014_bb0520","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2007.05.019","article-title":"Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles","volume":"122","author":"Chalasani","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.02.014_bb0525","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1073\/pnas.0400969101","article-title":"Intestinal villous M cells: an antigen entry site in the mucosal epithelium","volume":"101","author":"Jang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2014.02.014_bb0530","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejpb.2009.04.009","article-title":"Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination","volume":"73","author":"Fievez","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2014.02.014_bb0535","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1211\/0022357001774967","article-title":"Ileal uptake of polyalkylcyanoacrylate nanocapsules in the rat","volume":"52","author":"Damge","year":"2000","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.nano.2014.02.014_bb0540","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jconrel.2006.05.013","article-title":"Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation","volume":"114","author":"Cui","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.02.014_bb0545","doi-asserted-by":"crossref","first-page":"e1001147","DOI":"10.1371\/journal.ppat.1001147","article-title":"Enhancing oral vaccine potency by targeting intestinal m cells","volume":"6","author":"Azizi","year":"2010","journal-title":"Plos Pathogens"},{"key":"10.1016\/j.nano.2014.02.014_bb0550","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/BF00215747","article-title":"Transport of membrane-bound macromolecules by M-cells in follicle-associated epithelium of rabbit peyer patch","volume":"247","author":"Neutra","year":"1987","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.nano.2014.02.014_bb0555","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1084\/jem.184.3.1045","article-title":"Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting","volume":"184","author":"Frey","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.nano.2014.02.014_bb0560","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0016-5085(77)80254-0","article-title":"Sequential uptake of horseradish-peroxidase by lymphoid follicle epithelium of Peyers patches in normal unobstructed mouse intestine\u2014ultrastructure study","volume":"72","author":"Owen","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nano.2014.02.014_bb0565","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/BF02913722","article-title":"Selective binding and transcytosis of latex microspheres by rabbit intestinal M-cells","volume":"271","author":"Jepson","year":"1993","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.nano.2014.02.014_bb0570","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(01)00149-1","article-title":"Exploiting M cells for drug and vaccine delivery","volume":"50","author":"Clark","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2014.02.014_bb0575","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1768-322X.1987.tb00571.x","article-title":"Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine","volume":"61","author":"Aprahamian","year":"1987","journal-title":"Biol Cell"},{"key":"10.1016\/j.nano.2014.02.014_bb0580","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1007\/s11095-007-9367-4","article-title":"Alginate\/Chitosan nanoparticles are effective for oral insulin delivery","volume":"24","author":"Sarmento","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2014.02.014_bb0585","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijpharm.2007.08.051","article-title":"Beneficial properties for insulin absorption using superporous hydrogel containing interpenetrating polymer network as oral delivery vehicles","volume":"350","author":"Yin","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2014.02.014_bb0590","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ejps.2010.08.009","article-title":"Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles","volume":"41","author":"Woitiski","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2014.02.014_bb0595","first-page":"2733","article-title":"Advanced drug delivery to the lymphatic system: lipid-based nanoformulations","volume":"8","author":"Ali Khan","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2014.02.014_bb0600","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1166\/jnn.2006.425","article-title":"Transport characteristics of wheat germ agglutinin-modified insulin-liposomes and solid lipid nanoparticles in a perfused rat intestinal model","volume":"6","author":"Zhang","year":"2006","journal-title":"J Nanosci Nanotechnol"},{"key":"10.1016\/j.nano.2014.02.014_bb0605","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2012.02.009","article-title":"Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose","volume":"81","author":"Niu","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2014.02.014_bb0610","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1016\/j.biomaterials.2011.07.086","article-title":"Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins","volume":"32","author":"Sonaje","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2014.02.014_bb0615","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.drudis.2007.06.005","article-title":"Immunogenicity of protein therapeutics and the interplay between tolerance and antibody responses","volume":"12","author":"Barbosa","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.nano.2014.02.014_bb0620","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF00052777","article-title":"Insulin and colon-cancer","volume":"6","author":"Giovannucci","year":"1995","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.nano.2014.02.014_bb0625","first-page":"683","article-title":"Insulin and cancer (review)","volume":"18","author":"Argiles","year":"2001","journal-title":"Int J Oncol"},{"key":"10.1016\/j.nano.2014.02.014_bb0630","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1158\/1055-9965.EPI-10-0833","article-title":"Dietary insulin load, dietary insulin index, and colorectal cancer","volume":"19","author":"Bao","year":"2010","journal-title":"Cancer Epidemiol Biomarkers"},{"key":"10.1016\/j.nano.2014.02.014_bb0635","first-page":"553","article-title":"Gastrointestinal uptake and translocation of microparticles in the streptozotocin-diabetic rat","volume":"189","author":"McMinn","year":"1996","journal-title":"J Anat"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963414001178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963414001178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:45:09Z","timestamp":1716597909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963414001178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":127,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1549963414001178"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2014.02.014","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intestinal absorption of insulin nanoparticles: Contribution of M cells","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2014.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}